BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) is pleased to announce that BARD1 CEO Dr Leearne Hinch will be delivering the enclosed presentation to the Bell Potter Healthcare Conference today.
For more information, download the attached PDF.
Download this document
